id	sid	eid	entity	type
aji-137	102	1	#	CARDINAL
aji-137	102	2	gupta	PERSON
aji-137	102	3	sai rama konda	PERSON
aji-137	102	4	k. srija	PERSON
aji-137	102	5	g. pooja reddy	PERSON
aji-137	103	1	2024	DATE
aji-137	105	1	asian	NORP
aji-137	105	2	7	CARDINAL
aji-137	105	3	1):123-30	DATE
aji-137	107	1	asian	NORP
aji-137	107	2	7	CARDINAL
aji-137	107	3	1	CARDINAL
aji-137	107	4	123-130	CARDINAL
aji-137	107	5	2024	DATE
aji-137	107	6	nikita gupta	PERSON
aji-137	108	1	#	CARDINAL
aji-137	108	2	k. srija	PERSON
aji-137	108	3	#	CARDINAL
aji-137	108	4	g. pooja reddy	PERSON
aji-137	109	1	# a	MONEY
aji-137	109	2	st. pauls college	ORG
aji-137	109	3	hyderabad	GPE
aji-137	109	4	telangana	GPE
aji-137	109	5	india	GPE
aji-137	110	1	hyderabad	GPE
aji-137	110	2	telangana	GPE
aji-137	110	3	india	GPE
aji-137	113	1	https://doi.org/10.9734/aji/2024/v7i1137	LANGUAGE
aji-137	114	1	05/08/2024	DATE
aji-137	114	2	23/08/2024	CARDINAL
aji-137	118	1	https://doi.org/10.9734/aji/2024/v7i1137	PRODUCT
aji-137	118	2	gupta et al	PERSON
aji-137	118	3	asian	NORP
aji-137	118	4	j. immunol	PERSON
aji-137	118	5	7	CARDINAL
aji-137	118	6	1	CARDINAL
aji-137	119	1	123-130	CARDINAL
aji-137	119	2	2024	DATE
aji-137	119	3	124	CARDINAL
aji-137	120	1	five	CARDINAL
aji-137	120	2	3	CARDINAL
aji-137	120	3	kinase1	PERSON
aji-137	120	4	2	CARDINAL
aji-137	121	1	1	CARDINAL
aji-137	121	2	2	CARDINAL
aji-137	122	1	jak1	PERSON
aji-137	122	2	jak2	ORG
aji-137	122	3	1.	CARDINAL
aji-137	124	1	neisseria gonorrhoeae	PERSON
aji-137	125	1	1	CARDINAL
aji-137	127	1	1	CARDINAL
aji-137	129	1	2,3	CARDINAL
aji-137	132	1	fda	ORG
aji-137	133	1	5	CARDINAL
aji-137	134	1	jak1	GPE
aji-137	134	2	jak2	GPE
aji-137	134	3	6	CARDINAL
aji-137	135	1	jak1	GPE
aji-137	135	2	jak2	GPE
aji-137	135	3	five	CARDINAL
aji-137	135	4	3	CARDINAL
aji-137	136	1	adalimumab	PERSON
aji-137	138	1	1,7,8	CARDINAL
aji-137	140	1	jak1	PERSON
aji-137	140	2	jak2	GPE
aji-137	141	1	50	CARDINAL
aji-137	141	2	us	GPE
aji-137	141	3	japan	GPE
aji-137	141	4	european	NORP
aji-137	142	1	9	CARDINAL
aji-137	143	1	10,11	CARDINAL
aji-137	146	1	12	CARDINAL
aji-137	149	1	13	CARDINAL
aji-137	150	1	14	CARDINAL
aji-137	152	1	asian	NORP
aji-137	152	2	j. immunol	PERSON
aji-137	152	3	7	CARDINAL
aji-137	152	4	1	CARDINAL
aji-137	153	1	123-130	CARDINAL
aji-137	153	2	2024	DATE
aji-137	154	1	2 mg	QUANTITY
aji-137	154	2	4 mg	CARDINAL
aji-137	154	3	daily	DATE
aji-137	154	4	canada	GPE
aji-137	154	5	china	GPE
aji-137	154	6	2 mg	QUANTITY
aji-137	154	7	daily	DATE
aji-137	155	1	2	CARDINAL
aji-137	157	1	u.s.	GPE
aji-137	157	2	food and drug administration	ORG
aji-137	157	3	fda	ORG
aji-137	158	1	fda	ORG
aji-137	158	2	covid-19	PERSON
aji-137	162	1	5	CARDINAL
aji-137	162	2	al aman ahmad	PERSON
aji-137	163	1	2.	CARDINAL
aji-137	165	1	5,15	CARDINAL
aji-137	165	2	al anam ahmad	ORG
aji-137	165	3	amanda	PERSON
aji-137	165	4	four	CARDINAL
aji-137	165	5	tyk2	GPE
aji-137	165	6	jak1	GPE
aji-137	165	7	jak2	GPE
aji-137	165	8	jak 3	DATE
aji-137	168	1	5,16	CARDINAL
aji-137	168	2	al anam ahmad	ORG
aji-137	168	3	francesca	PERSON
aji-137	169	1	jak1	GPE
aji-137	169	2	jak2	GPE
aji-137	172	1	jak1/jak2	GPE
aji-137	173	1	one week	DATE
aji-137	175	1	interleukin-15	PERSON
aji-137	176	1	baricitinib	ORG
aji-137	177	1	al anam ahmad	ORG
aji-137	178	1	brett king	PERSON
aji-137	178	2	m.d.	GPE
aji-137	178	3	ph.d	ORG
aji-137	179	1	3	CARDINAL
aji-137	179	2	97%	PERCENT
aji-137	180	1	baricitinib	PERSON
aji-137	180	2	1.5 hours	TIME
aji-137	180	3	0.5 to 3 hours	TIME
aji-137	182	1	approximately 50%	PERCENT
aji-137	183	1	baricitinib	ORG
aji-137	183	2	76 l	DATE
aji-137	184	1	approximately 10%	PERCENT
aji-137	184	2	3a4	CARDINAL
aji-137	185	1	oat3	LOC
aji-137	185	2	two-fold	CARDINAL
aji-137	186	1	half	CARDINAL
aji-137	186	2	5	CARDINAL
aji-137	186	3	al anam ahmad	ORG
aji-137	187	1	20%	PERCENT
aji-137	187	2	about 75%	PERCENT
aji-137	188	1	approximately 12-hour	TIME
aji-137	188	2	half	CARDINAL
aji-137	188	3	about 12	CARDINAL
aji-137	189	1	5,18	CARDINAL
aji-137	189	2	al anam ahmad	ORG
aji-137	190	1	jack g. shi phd	PERSON
aji-137	191	1	gupta et al	PERSON
aji-137	191	2	asian	NORP
aji-137	191	3	j. immunol	PERSON
aji-137	191	4	7	CARDINAL
aji-137	191	5	1	CARDINAL
aji-137	192	1	123-130	CARDINAL
aji-137	192	2	2024	DATE
aji-137	193	1	4.1	CARDINAL
aji-137	193	2	baricitinib	ORG
aji-137	193	3	two	CARDINAL
aji-137	193	4	2 mg	QUANTITY
aji-137	193	5	4 mg	QUANTITY
aji-137	194	1	2 mg	QUANTITY
aji-137	195	1	2 mg	QUANTITY
aji-137	195	2	10–14 days	DATE
aji-137	195	3	covid-19	ORG
aji-137	195	4	19	CARDINAL
aji-137	195	5	al feng huang	PERSON
aji-137	195	6	4.2	CARDINAL
aji-137	195	7	2 mg	QUANTITY
aji-137	197	1	covid-19	PERSON
aji-137	197	2	covid-19	GPE
aji-137	198	1	4 mg	QUANTITY
aji-137	198	2	baricitinib	ORG
aji-137	198	3	14 days	DATE
aji-137	199	1	20	CARDINAL
aji-137	199	2	al s honda	ORG
aji-137	200	1	4.3	CARDINAL
aji-137	202	1	al egídio freitas	ORG
aji-137	202	2	t bieber	GPE
aji-137	202	3	n katoh	PERSON
aji-137	204	1	baricitinib	ORG
aji-137	205	1	12 weeks	DATE
aji-137	206	1	al d van der heijde	ORG
aji-137	206	2	27	CARDINAL
aji-137	206	3	taylor	PERSON
aji-137	207	1	4.4	CARDINAL
aji-137	207	2	the mid-1990s	DATE
aji-137	209	1	jak1	PERSON
aji-137	209	2	jak2	GPE
aji-137	210	1	25,26	CARDINAL
aji-137	210	2	al mark c. genovese	PERSON
aji-137	210	3	m.d.	GPE
aji-137	210	4	joel kremer	PERSON
aji-137	210	5	m.d.	GPE
aji-137	210	6	omid zamani	PERSON
aji-137	210	7	m.d.	GPE
aji-137	210	8	jj o'shea	PERSON
aji-137	210	9	j israel	PERSON
aji-137	210	10	hakobyan	NORP
aji-137	212	1	second	ORDINAL
aji-137	214	1	27,28	CARDINAL
aji-137	214	2	al ivan urits1	PERSON
aji-137	214	3	jacob israel2	PERSON
aji-137	215	1	the mid-1990s	DATE
aji-137	217	1	baricitinib	ORG
aji-137	217	2	jak1	GPE
aji-137	217	3	jak2	GPE
aji-137	220	1	gupta et al	PERSON
aji-137	220	2	asian	NORP
aji-137	220	3	j. immunol	PERSON
aji-137	220	4	7	CARDINAL
aji-137	220	5	1	CARDINAL
aji-137	221	1	123-130	CARDINAL
aji-137	221	2	2024	DATE
aji-137	221	3	no.aji.120135 127	ORG
aji-137	221	4	12 weeks	DATE
aji-137	224	1	baricitinib	ORG
aji-137	225	1	25	CARDINAL
aji-137	225	2	al mark c. genovese	PERSON
aji-137	225	3	m.d.	GPE
aji-137	225	4	joel kremer	PERSON
aji-137	225	5	m.d.	GPE
aji-137	225	6	omid zamani	PERSON
aji-137	225	7	m.d. 4.5	PERSON
aji-137	225	8	2	CARDINAL
aji-137	225	9	301	CARDINAL
aji-137	225	10	ra(rheumatoid	ORG
aji-137	226	1	week 12	DATE
aji-137	226	2	76%	PERCENT
aji-137	226	3	4	CARDINAL
aji-137	226	4	20	CARDINAL
aji-137	227	1	29	CARDINAL
aji-137	227	2	al david t. felson	PERSON
aji-137	227	3	mph	CARDINAL
aji-137	227	4	41%	PERCENT
aji-137	227	5	30	CARDINAL
aji-137	227	6	al david t. felson	PERSON
aji-137	227	7	md	GPE
aji-137	228	1	4 mg	QUANTITY
aji-137	229	1	2	CARDINAL
aji-137	229	2	145	CARDINAL
aji-137	229	3	japanese	NORP
aji-137	230	1	week 12	DATE
aji-137	230	2	4 mg	QUANTITY
aji-137	230	3	8 mg	QUANTITY
aji-137	230	4	77%	PERCENT
aji-137	230	5	31%	PERCENT
aji-137	230	6	31	CARDINAL
aji-137	230	7	al yoshiya tanaka	PERSON
aji-137	231	1	week 12	DATE
aji-137	231	2	2	CARDINAL
aji-137	231	3	4	DATE
aji-137	231	4	8 mg	QUANTITY
aji-137	232	1	4	CARDINAL
aji-137	232	2	as early as week 2	DATE
aji-137	232	3	1	CARDINAL
aji-137	232	4	al satoshi kubo	PERSON
aji-137	233	1	4.6	CARDINAL
aji-137	233	2	six	CARDINAL
aji-137	233	3	3	CARDINAL
aji-137	235	1	baricitinib	PERSON
aji-137	236	1	1	CARDINAL
aji-137	236	2	al satoshi kubo	PERSON
aji-137	237	1	jade(jak1	NORP
aji-137	237	2	527	CARDINAL
aji-137	238	1	week 12	DATE
aji-137	238	2	55%	PERCENT
aji-137	238	3	27%	PERCENT
aji-137	238	4	32	CARDINAL
aji-137	238	5	al charles ludivico	PERSON
aji-137	238	6	m.d.	PERSON
aji-137	239	1	sdai(simple	ORG
aji-137	240	1	weill cornell medical college	ORG
aji-137	240	2	06:35	TIME
aji-137	240	3	july 20, 2016.	DATE
aji-137	241	1	week 24	DATE
aji-137	241	2	4	CARDINAL
aji-137	243	1	33	CARDINAL
aji-137	243	2	al dario ummarino	PERSON
aji-137	244	1	4.7	CARDINAL
aji-137	244	2	32	CARDINAL
aji-137	244	3	charles ludivico	PERSON
aji-137	244	4	m.d	PERSON
aji-137	244	5	527	CARDINAL
aji-137	244	6	at least one	CARDINAL
aji-137	245	1	the 2 mg	PRODUCT
aji-137	245	2	4 mg	QUANTITY
aji-137	245	3	71%	PERCENT
aji-137	245	4	77%	PERCENT
aji-137	245	5	64%	PERCENT
aji-137	245	6	44% and 40%	PERCENT
aji-137	245	7	31%	PERCENT
aji-137	248	1	4%	PERCENT
aji-137	248	2	10%	PERCENT
aji-137	248	3	7%	PERCENT
aji-137	248	4	three	CARDINAL
aji-137	250	1	only two	CARDINAL
aji-137	250	2	4	CARDINAL
aji-137	251	1	two	CARDINAL
aji-137	251	2	one	CARDINAL
aji-137	251	3	4 mg	TIME
aji-137	251	4	one	CARDINAL
aji-137	251	5	4 mg	TIME
aji-137	251	6	one	CARDINAL
aji-137	254	1	asian	NORP
aji-137	254	2	j. immunol	PERSON
aji-137	254	3	7	CARDINAL
aji-137	254	4	1	CARDINAL
aji-137	255	1	123-130	CARDINAL
aji-137	255	2	2024	DATE
aji-137	255	3	no.aji.120135 128	ORG
aji-137	255	4	1	CARDINAL
aji-137	255	5	al satoshi kubo	PERSON
aji-137	256	1	5.	CARDINAL
aji-137	257	1	baricitinib	ORG
aji-137	257	2	jak1	GPE
aji-137	257	3	jak2	GPE
aji-137	257	4	jak3	ORG
aji-137	257	5	tyk2	GPE
aji-137	259	1	copilot	ORG
aji-137	261	1	1	CARDINAL
aji-137	262	1	kubo s	PERSON
aji-137	262	2	nakayamada s	ORG
aji-137	262	3	tanaka y. baricitinib	PERSON
aji-137	264	1	2016;12(9):911-9	CARDINAL
aji-137	264	2	2	CARDINAL
aji-137	264	3	emery p	PERSON
aji-137	264	4	durez p	ORG
aji-137	264	5	hueber aj	PERSON
aji-137	264	6	de la torre	PERSON
aji-137	265	1	larsson e	PERSON
aji-137	265	2	tanaka y. baricitinib	PERSON
aji-137	267	1	2021;23:1-3	DATE
aji-137	267	2	3	CARDINAL
aji-137	270	1	2018;320(13):1360-72	DATE
aji-137	271	1	4	CARDINAL
aji-137	271	2	schett g. cellular	PERSON
aji-137	273	1	berlin/heidelberg	ORG
aji-137	273	2	springer berlin heidelberg	PERSON
aji-137	274	1	2017;39(4):355-363	CARDINAL
aji-137	275	1	5	CARDINAL
aji-137	276	1	ahmad	PERSON
aji-137	276	2	zaheer m	ORG
aji-137	276	3	balis fj	GPE
aji-137	276	4	baricitinib	PERSON
aji-137	278	1	2022	CARDINAL
aji-137	279	1	6	CARDINAL
aji-137	279	2	genovese mc	PERSON
aji-137	279	3	takeuchi t	PERSON
aji-137	279	4	burmester g	PERSON
aji-137	279	5	rooney tp	PERSON
aji-137	279	6	zhong j	PERSON
aji-137	279	7	daojun m	PERSON
aji-137	279	8	issa m.	PERSON
aji-137	279	9	3 years	DATE
aji-137	281	1	2020;2(6):e347	CARDINAL
aji-137	282	1	7	CARDINAL
aji-137	282	2	smolen	PERSON
aji-137	282	3	bijlsma jw	PERSON
aji-137	282	4	breedveld fc	PERSON
aji-137	282	5	burmester g	PERSON
aji-137	282	6	combe	PERSON
aji-137	282	7	cutolo m	PERSON
aji-137	284	1	2010;69(4):631-7	DATE
aji-137	284	2	8	CARDINAL
aji-137	285	1	smolen	PERSON
aji-137	285	2	breedveld fc	PERSON
aji-137	285	3	burmester gr	PERSON
aji-137	285	4	emery p	PERSON
aji-137	285	5	kvien tk	PERSON
aji-137	285	6	navarro-compán mv	PERSON
aji-137	285	7	oliver s	PERSON
aji-137	285	8	schoels m	ORG
aji-137	285	9	2014	DATE
aji-137	287	1	2016;75(1):3-15	CARDINAL
aji-137	288	1	9	CARDINAL
aji-137	288	2	taylor	PERSON
aji-137	288	3	burmester gr	PERSON
aji-137	288	4	rooney tp	PERSON
aji-137	288	5	witt s	PERSON
aji-137	288	6	issa m	PERSON
aji-137	288	7	zhang x	PERSON
aji-137	288	8	cardoso a. cardiovascular	PERSON
aji-137	290	1	2019;71(7	CARDINAL
aji-137	290	2	1042-55	CARDINAL
aji-137	291	1	10	CARDINAL
aji-137	292	1	smolen	PERSON
aji-137	292	2	fc	ORG
aji-137	292	3	burmester g	PERSON
aji-137	292	4	gaujoux	PERSON
aji-137	292	5	gossec l	ORG
aji-137	292	6	ramiro s.	PERSON
aji-137	292	7	2013	CARDINAL
aji-137	294	1	2014;73(3):492-509	CARDINAL
aji-137	294	2	11	CARDINAL
aji-137	295	1	singh ja	PERSON
aji-137	295	2	jr sl	PERSON
aji-137	295	3	akl ea	PERSON
aji-137	295	4	sullivan mc	PERSON
aji-137	295	5	mcnaughton	PERSON
aji-137	295	6	rh	ORG
aji-137	295	7	curtis jr.	PERSON
aji-137	295	8	2015	CARDINAL
aji-137	295	9	american college of rheumatology guideline	ORG
aji-137	297	1	2016;68(1):1	CARDINAL
aji-137	298	1	12	CARDINAL
aji-137	299	1	smolen	PERSON
aji-137	302	1	2015;11	CARDINAL
aji-137	302	2	5):276 89	DATE
aji-137	303	1	13	CARDINAL
aji-137	304	1	genovese mc	PERSON
aji-137	304	2	kremer	PERSON
aji-137	304	3	zamani o	PERSON
aji-137	304	4	krogulec m	PERSON
aji-137	304	5	xie l	PERSON
aji-137	304	6	koch ae	PERSON
aji-137	304	7	cardillo te	PERSON
aji-137	304	8	rooney tp	PERSON
aji-137	304	9	macias wl	PERSON
aji-137	304	10	baricitinib	ORG
aji-137	305	1	new england journal of medicine	ORG
aji-137	306	1	2016;374(13):1243	CARDINAL
aji-137	307	1	14	CARDINAL
aji-137	308	1	genovese mc	PERSON
aji-137	308	2	kremer jm	PERSON
aji-137	308	3	kartman ce	PERSON
aji-137	308	4	schlichting de	ORG
aji-137	308	5	xie l	ORG
aji-137	308	6	carmack t	ORG
aji-137	308	7	sanchez burson j	PERSON
aji-137	308	8	gupta et al	PERSON
aji-137	308	9	asian	NORP
aji-137	308	10	j. immunol	PERSON
aji-137	308	11	7	CARDINAL
aji-137	308	12	1	CARDINAL
aji-137	309	1	123-130	CARDINAL
aji-137	309	2	2024	DATE
aji-137	310	1	no.aji.120135	GPE
aji-137	310	2	macias wl	PERSON
aji-137	310	3	rooney tp	PERSON
aji-137	312	1	15	CARDINAL
aji-137	313	1	corsi k	PERSON
aji-137	313	2	mcauliffe l. baricitinib	PERSON
aji-137	313	3	second	ORDINAL
aji-137	313	4	fda	ORG
aji-137	315	1	2019;53(9):947-53	CARDINAL
aji-137	316	1	16	CARDINAL
aji-137	317	1	greco	PERSON
aji-137	317	2	ibrahim mm	PERSON
aji-137	317	3	grossi g	PERSON
aji-137	317	4	schenone s.	PERSON
aji-137	319	1	2019	DATE
aji-137	319	2	26(10):1806	CARDINAL
aji-137	320	1	17	CARDINAL
aji-137	321	1	ohyama m	ORG
aji-137	321	2	zlotogorski	PERSON
aji-137	321	3	ko j	PERSON
aji-137	321	4	hordinsky	PERSON
aji-137	321	5	dutronc y	PERSON
aji-137	321	6	wu ws	PERSON
aji-137	321	7	mccollam j	PERSON
aji-137	321	8	two	CARDINAL
aji-137	321	9	3	CARDINAL
aji-137	322	1	new england journal of medicine	ORG
aji-137	323	1	2022;386(18):1687-99	CARDINAL
aji-137	323	2	18	CARDINAL
aji-137	324	1	shi jg	PERSON
aji-137	324	2	chen x	PERSON
aji-137	324	3	lee f	PERSON
aji-137	324	4	emm t	PERSON
aji-137	324	5	scherle pa	GPE
aji-137	324	6	lo y	PERSON
aji-137	324	7	williams wv	GPE
aji-137	324	8	yeleswaram s.	ORG
aji-137	324	9	1/2	CARDINAL
aji-137	326	1	2014;54(12):1354-61	CARDINAL
aji-137	328	1	huang f	PERSON
aji-137	328	2	luo zc	PERSON
aji-137	328	3	2	CARDINAL
aji-137	328	4	4	CARDINAL
aji-137	328	5	daily	DATE
aji-137	330	1	2018;32(5):415-23	CARDINAL
aji-137	330	2	20	CARDINAL
aji-137	331	1	honda	ORG
aji-137	331	2	harigai m.	PERSON
aji-137	333	1	2020;19(5):545-51	CARDINAL
aji-137	333	2	21	CARDINAL
aji-137	334	1	torres t. baricitinib	PERSON
aji-137	336	1	2023;83(9):761-770	CARDINAL
aji-137	337	1	22	CARDINAL
aji-137	338	1	simpson el	GPE
aji-137	338	2	de bruinweller	PERSON
aji-137	338	3	grond s	FAC
aji-137	338	4	issa m	PERSON
aji-137	338	5	1.6 years	DATE
aji-137	338	6	up to 3.9 years	DATE
aji-137	338	7	eight	CARDINAL
aji-137	340	1	2023;34(1):2161812.*/ 23	DATE
aji-137	341	1	taylor	PERSON
aji-137	341	2	keystone ec	PERSON
aji-137	341	3	van der heijde	PERSON
aji-137	341	4	del carmen morales l	PERSON
aji-137	341	5	reyes gonzaga j	PERSON
aji-137	341	6	emoto k	PERSON
aji-137	341	7	beattie s	PERSON
aji-137	341	8	arora v. baricitinib versus	PERSON
aji-137	342	1	new england journal of medicine	ORG
aji-137	343	1	2017;376(7):652-62	DATE
aji-137	344	1	24	CARDINAL
aji-137	345	1	taylor	PERSON
aji-137	345	2	kremer jm	PERSON
aji-137	345	3	emery p	PERSON
aji-137	345	4	zuckerman	PERSON
aji-137	345	5	zhong j	PERSON
aji-137	345	6	chen l	PERSON
aji-137	345	7	witt s	PERSON
aji-137	345	8	kurzawa m	PERSON
aji-137	345	9	otvos jd	PERSON
aji-137	347	1	2018;77(7):988-95	CARDINAL
aji-137	348	1	25	CARDINAL
aji-137	349	1	genovese mc	PERSON
aji-137	349	2	kremer	PERSON
aji-137	349	3	zamani o	PERSON
aji-137	349	4	krogulec m	PERSON
aji-137	349	5	xie l	PERSON
aji-137	349	6	koch ae	PERSON
aji-137	349	7	cardillo te	PERSON
aji-137	349	8	rooney tp	PERSON
aji-137	349	9	macias wl	PERSON
aji-137	349	10	baricitinib	ORG
aji-137	350	1	new england journal of medicine	ORG
aji-137	351	1	13):124352	CARDINAL
aji-137	351	2	26	CARDINAL
aji-137	352	1	o’shea	NORP
aji-137	352	2	kanno y	PERSON
aji-137	352	3	chan ac	PERSON
aji-137	355	1	227-40	CARDINAL
aji-137	356	1	27	CARDINAL
aji-137	357	1	israel	GPE
aji-137	357	2	yusin g	PERSON
aji-137	357	3	lassiter g	PERSON
aji-137	357	4	berger aa	PERSON
aji-137	357	5	viswanath o. baricitinib	PERSON
aji-137	359	1	2020;58(6	CARDINAL
aji-137	359	2	407	CARDINAL
aji-137	360	1	28	CARDINAL
aji-137	361	1	israel	GPE
aji-137	361	2	yusin g	PERSON
aji-137	361	3	lassiter g	PERSON
aji-137	361	4	berger aa	PERSON
aji-137	361	5	viswanath o. baricitinib	PERSON
aji-137	363	1	2020;58(6	CARDINAL
aji-137	363	2	407	CARDINAL
aji-137	364	1	felson	PERSON
aji-137	364	2	anderson jj	PERSON
aji-137	364	3	boers	NORP
aji-137	364	4	katz lm	PERSON
aji-137	364	5	lightfoot jr r	PERSON
aji-137	364	6	paulus h	ORG
aji-137	364	7	tugwell p.	ORG
aji-137	364	8	american	NORP
aji-137	365	1	the american college of rheumatology	ORG
aji-137	366	1	1995;38(6):727	CARDINAL
aji-137	366	2	30	CARDINAL
aji-137	367	1	tanaka y	PERSON
aji-137	367	2	emoto k	PERSON
aji-137	368	1	aoki t	PERSON
aji-137	368	2	rooney t	PERSON
aji-137	368	3	macias w.	PERSON
aji-137	368	4	japanese	NORP
aji-137	368	5	12-week	DATE
aji-137	369	1	the journal of rheumatology	ORG
aji-137	370	1	2016	DATE
aji-137	370	2	43(3):504-11 31	DATE
aji-137	371	1	genovese mc	PERSON
aji-137	371	2	kremer	PERSON
aji-137	371	3	zamani o	PERSON
aji-137	371	4	krogulec m	PERSON
aji-137	371	5	xie l	PERSON
aji-137	371	6	koch ae	PERSON
aji-137	371	7	cardillo te	PERSON
aji-137	371	8	rooney tp	PERSON
aji-137	371	9	macias wl	PERSON
aji-137	371	10	baricitinib	ORG
aji-137	372	1	new england journal of medicine	ORG
aji-137	374	1	gupta et al	PERSON
aji-137	374	2	asian	NORP
aji-137	374	3	j. immunol	PERSON
aji-137	375	1	7	CARDINAL
aji-137	375	2	1	CARDINAL
aji-137	376	1	123-130	CARDINAL
aji-137	376	2	2024	DATE
aji-137	377	1	d. ra-beacon	PERSON
aji-137	380	1	33	DATE
aji-137	381	1	radu af	PERSON
aji-137	381	2	bungau sg	ORG
aji-137	466	1	2024	DATE